United States & American Society of Clinical Oncology
14 shared events · Importance 3 · Last updated Aug 24, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Tech
United States: U.S. regulators added a black box warning to Ozempic in June 2026 regarding thyroid cancer risk, and the FDA's stance is part of the regulatory context. The event may influence future regulatory decisions.
American Society of Clinical Oncology: The annual meeting served as a platform for presenting new research on GLP-1 drugs and cancer, contributing to the scientific discourse and media attention.
Jul 13, 2026 · 6 articles
Tech
United States: The studies discussed involve patients and practices within the United States>>> and address a significant health concern for American women.
American Society of Clinical Oncology: The American Society of Clinical Oncology>>> Annual Meeting served as the platform for presenting the significant research findings on GLP-1 receptor agonist and breast cancer prevention.
Jun 02, 2026 · 45 articles
Tech
United States: The United States>>> was the location of the U.S.-led study of daraxonrasib and the initial application for drug licensing to the United States — Food and Drug Administration>>>.
American Society of Clinical Oncology: The American Society of Clinical Oncology meeting in Chicago was the venue where the significant findings of the daraxonrasib study were presented to the medical community.
May 29, 2026 · 74 articles
Tech
United States: The United States will host the presentation of the study's findings at the American Society of Clinical Oncology's annual meeting in Chicago.
American Society of Clinical Oncology: The American Society of Clinical Oncology is hosting its annual meeting where the groundbreaking results of the OPTIMA trial are being presented, disseminating the findings to a global audience of cancer specialists.
May 29, 2026 · 21 articles
Tech
United States: The United States hosted the American Society of Clinical Oncology Annual Meeting in Chicago, where the study results were presented.
American Society of Clinical Oncology: The American Society of Clinical Oncology hosted the annual meeting where the study results for SKB500 were presented, serving as a key platform for disseminating medical advancements.
Jun 03, 2026 · 6 articles
Tech
United States: The US is the primary market for the treatment, with regulatory approval and healthcare system implications.
American Society of Clinical Oncology: ASCO's chief medical officer called the results a 'monumental leap forward,' and the organization hosted the Phase 2 data presentation.
Aug 19, 2026 · 108 articles
Tech
United States: The United States>>> is a key market for prostate cancer treatment, with a significant number of high-risk patients who could benefit from Apalutamide>>>.
American Society of Clinical Oncology: The American Society of Clinical Oncology>>> meeting served as the platform for presenting the groundbreaking trial data for Apalutamide>>>.
May 31, 2026 · 6 articles
Tech
United States: The United States is a key market for IBI363, with Innovent Biologics and Takeda Pharmaceutical Company co-commercializing the drug there. The U.S. FDA has granted Fast Track Designations for IBI363.
American Society of Clinical Oncology: The American Society of Clinical Oncology (ASCO) Annual Meeting is the platform where the updated clinical data for IBI363 was presented, providing a significant forum for disseminating these important findings to the medical and scientific community.
May 21, 2026 · 9 articles
Tech
United States: The guideline is relevant to U.S. healthcare, potentially affecting treatment patterns and costs for pancreatic cancer patients.
American Society of Clinical Oncology: ASCO collaborated on the guideline, reinforcing its role in multidisciplinary cancer care and potentially influencing its members' practices.
Aug 13, 2026 · 6 articles
Tech
United States: United States>>> is one of the countries where patients were enrolled for the KEYNOTE-942 trial, contributing to the global scope of the research. Its involvement highlights its participation in international medical studies and its significant burden of skin cancer cases.
American Society of Clinical Oncology: The American Society of Clinical Oncology>>> is hosting the presentation of the trial results, solidifying its role as a central platform for disseminating significant cancer research. This event enhances its prestige and influence within the oncology community.
Jun 01, 2026 · 6 articles
Business
United States: Zegfrovy is approved in the US; FDA granted Breakthrough Therapy Designation for first-line use.
American Society of Clinical Oncology: ASCO hosted presentation of WU-KONG28 trial results as a Late-Breaking Abstract.
Jul 14, 2026 · 8 articles
Tech
United States: The United States is relevant as the country where golidocitinib received Fast Track Designation from the United States — Food and Drug Administration (FDA).
American Society of Clinical Oncology: The American Society of Clinical Oncology (ASCO) Annual Meeting served as the platform for Dizal Pharmaceutical to present its clinical trial results, providing a credible forum for dissemination.
May 31, 2026 · 6 articles
Business
United States: Kaveri is based in the U.S., where clinical trials will be conducted.
American Society of Clinical Oncology: ASCO meetings provided the platform where positive data for the programs were presented, validating their potential.
Jul 21, 2026 · 7 articles
Tech
American Society of Clinical Oncology: The American Society of Clinical Oncology (ASCO) is the host of the annual meeting where new cancer research and clinical development advances are presented, making it a central entity for this event.
May 25, 2026 · 33 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States and American Society of Clinical Oncology interact across events, view sentiment trends, and discover connected entities.
Open Dashboard